Skinbiotherapeutics【SBTX】銘柄情報

Skinbiotherapeutics Plc (SBTX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

11.50

( 4.55% )

買値

11.00

売値

12.00

出来高

109,050

11.50 日の範囲 11.50

5.20 52 週間の範囲 22.50

時価総額

29.804M

前日終値

11.00

始値

11.50

時刻

20630

11.3251

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

1,830,613p

発行済株式数

259,168,671

配当利回り

PER

-45.77

1 株当たり利益 (EPS)

-0

歳入

5.23M

純利益

-456.41k

SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome ... SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with Croda Plc for the development of SkinBiotix as an active ingredient for the skicare and cosmetic industry. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.skinbiotherapeutics.com

本社

Newcastle Upon Tyne, United Kingdom

設立

2026

Skinbiotherapeutics Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker SBTX. The last closing price for Skinbiotherapeutics was 11p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 5.20p to 22.50p.

Skinbiotherapeutics currently has 259,168,671 shares in issue. The market capitalisation of Skinbiotherapeutics is £29.80 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -45.77.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	5	76.9230769231	6.5	12.5	6.5	1588444	10.25299869	DE
4	3.5	43.75	8	12.5	6.25	1579782	9.35646454	DE
12	2.5	27.7777777778	9	12.5	6.25	1582109	9.4710023	DE
26	-1.75	-13.2075471698	13.25	22.5	5.2	4002618	10.74320013	DE
52	-5.375	-31.8518518519	16.875	22.5	5.2	2131940	12.07982919	DE
156	-0.925	-7.44466800805	12.425	29.5	5.2	1253394	13.93962784	DE
260	-53	-82.1705426357	64.5	77.5	5.2	918840	18.71569487	DE